芪藶強(qiáng)心膠囊治療心房顫動(dòng)合并心力衰竭療效觀察

[摘要] 目的 分析使用芪藶強(qiáng)心膠囊治療心房顫動(dòng)合并心力衰竭的臨床療效。方法 選取2012年8月—2014年9月于該院收治的心房顫動(dòng)合并心力衰竭患者共90例，依據(jù)隨機(jī)原則分為治療組（口服芪藶強(qiáng)心膠囊）與對(duì)照組（應(yīng)用常規(guī)的方法）各45例，比較以上兩組治療前后的臨床效果及痊愈情況。結(jié)果 對(duì)比治療組和對(duì)照組臨床療效，經(jīng)研究得出治療組中患者的痊愈數(shù)量為28例，明顯高于對(duì)照組的15例，治療組總有效率95.6%高于對(duì)照組77.8%， 因此，治療組的療效優(yōu)于對(duì)照組的療效，有統(tǒng)計(jì)學(xué)意。結(jié)論 給予患者服用芪藶強(qiáng)心膠囊進(jìn)行治療，有利于患者的早日痊愈，恢復(fù)健康，其臨床療效具有使用價(jià)值。

[關(guān)鍵詞] 芪藶強(qiáng)心膠囊；心房顫動(dòng)；心力衰竭；治療

[中圖分類號(hào)] R4 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-0742（2015）05（c）-0158-02

[Abstract] Objective To evaluate the clinical effect of using Qiliqiangxin capsule in the treatment of atrial fibrillation with congestive heart failure. Methods From 2012 August -2014 year in September in our hospital of atrial fibrillation in patients with heart failure and 90 cases， according to the principle of random divided into treatment group and control group with 45 cases in each group， the clinical effects were compared before and after the above two groups of treatment and cure condition. Results Compared with treatment group and control group， the clinical efficacy， the study concluded the patients in treatment group recovered was 28， significantly higher than the control group with 15 cases， the total effective rate of treatment group was higher than that in the control group， the total efficiency， therefore， the efficacy of the treatment group curative effect surpasses the control group had statistical significance. ConclusionFor the treatment of atrial fibrillation in patients with heart failure using the conventional method and give the taking of Qiliqiangxin capsule treatment， is beneficial to the patients recover soon， to restore health， its clinical efficacy has use value.

[Key words] Qiliqiangxin capsule； Atrial fibrillation； Heart failure； Therapy

近幾年以來，芪藶強(qiáng)心膠囊是我國(guó)結(jié)合相關(guān)絡(luò)病理論指導(dǎo)研發(fā)的治療心力衰竭及心房顫動(dòng)的新藥[1]。該研究通過選取2012年8月—2014年9月于該院收治的心房顫動(dòng)合并心力衰竭患者共90例，主要分析口服芪藶強(qiáng)心膠囊對(duì)心房顫動(dòng)合并心力衰竭患者的臨床療效，現(xiàn)將具體研究?jī)?nèi)容整理報(bào)道如下。

1 資料與方法

1.1 一般資料

該研究通過選取2012年8月—2014年9月于該院收治的心房顫動(dòng)合并心力衰竭患者共90例，作為該組的研究對(duì)象。依據(jù)心房顫動(dòng)合并心力衰竭診斷標(biāo)準(zhǔn)[2]，根據(jù)隨機(jī)原則將患者分為治療組和對(duì)照組各45例，治療組中男性患者23例，女性患者22例，患者年齡46～79歲，平均年齡（60.48±6.97）歲，病程1～5年，平均病程（2.12±0.12）年，其中風(fēng)濕性心臟病13例，高血壓心臟病15例，擴(kuò)張型心肌病8例，退行性瓣膜病9例；……